Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: The DCB-only All-Comers Registry.

Mark Rosenberg Matthias W WaliszewskiKenneth ChinWan Azman Wan AhmadGiuseppe CaramannoDiego MilazzoAmin Ariff NuruddinHoung Bang LiewOteh MaskonPierre AubryRaphael PoyetNorbert Frey

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)

Our results show that DCB-only angioplasty of de-novo coronary lesions is associated with low MACE and TLR rates. Thus, DCBs appear to be an attractive alternative for the interventional, stentless treatment of suitable de-novo coronary lesions.

Keyphrases

coronary artery disease
coronary artery
aortic stenosis
toll like receptor
immune response
study protocol
inflammatory response
emergency department
phase iii
heart failure
randomized controlled trial
drug induced
transcatheter aortic valve replacement
ejection fraction
open label
smoking cessation